GLP1R Agonists and Precision Medicine: In Search of Predictive Biomarkers

被引:0
|
作者
Bagheri, Sayna [1 ]
Pilla, Scott J. [2 ,3 ,4 ]
Taylor, Simeon, I [5 ]
机构
[1] Univ Tehran Med Sci, Fac Med, Tehran 1416634793, Iran
[2] Johns Hopkins Univ, Sch Med, Dept Med, Div Gen Internal Med, Baltimore, MD 21287 USA
[3] Johns Hopkins Univ, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21287 USA
[4] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD 21287 USA
[5] Univ Maryland, Sch Med, Dept Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA
来源
关键词
GLP1; GIP; tirzepatide; latent autoimmune diabetes of adults; glutamic acid decarboxylase autoantibodies; type; 2; diabetes; GIP; EFFICACY;
D O I
10.1210/clinem/dgae548
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:e1272 / e1273
页数:2
相关论文
共 50 条
  • [1] GLP1R agonists in NAFLD: a promising therapy on the horizon
    Bany Bakar, Rula
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2023, 20 (06) : 346 - 346
  • [2] Impact of GLP1R and its agonists in pulmonary circulation
    Jeremic, Dusan
    Nagy, Bence
    Eller, Kathrin
    Hoetzenecker, Konrad
    Olschewski, Horst
    Olschewski, Andrea
    Nagaraj, Chandran
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [3] GLP1R agonists in NAFLD: a promising therapy on the horizon
    Rula Bany Bakar
    Nature Reviews Gastroenterology & Hepatology, 2023, 20 : 346 - 346
  • [4] GLP1R agonists: primary cardiovascular prevention and oral administration
    Lim, Gregory B.
    NATURE REVIEWS CARDIOLOGY, 2019, 16 (08) : 453 - 453
  • [5] GLP1R agonists: primary cardiovascular prevention and oral administration
    Gregory B. Lim
    Nature Reviews Cardiology, 2019, 16 : 453 - 453
  • [6] Genetic approach supports cardiovascular safety of GLP1R agonists
    Irene Fernández-Ruiz
    Nature Reviews Cardiology, 2016, 13 (8) : 444 - 444
  • [7] Renoprotective effects of GLP1R agonists and SGLT2 inhibitors
    Berthold Hocher
    Oleg Tsuprykov
    Nature Reviews Nephrology, 2017, 13 : 728 - 730
  • [8] Renoprotective effects of GLP1R agonists and SGLT2 inhibitors
    Hocher, Berthold
    Tsuprykov, Oleg
    NATURE REVIEWS NEPHROLOGY, 2017, 13 (12) : 728 - 729
  • [9] Association Between GLP1R Agonists and Prostate, Kidney, and Bladder Cancers
    Bukavina, Laura
    Helstrom, Emma
    Wallis, Christopher J. D.
    Fulmes, Antoniy
    Calaway, Adam
    Correa, Andres
    Rhodes, Stephen
    EUROPEAN UROLOGY ONCOLOGY, 2024, 7 (06): : 1543 - 1544
  • [10] Developing a translational tool for GLP-1-based therapeutic agonists in humanized GLP1R mice
    Shen, Yuelei
    Yao, Jiawei
    Kokabee, Mostafa
    Guo, Yanan
    Ba, Yang, I
    Shang, Chengzhang
    CANCER RESEARCH, 2022, 82 (12)